DAY TWO: Regulation & CommercializationWednesday, 2 December 2026

Drawing on the development of a global regulatory compendium covering 32 countries, Terry Stone will examine what regulatory professionals need to understand when entering a new market—and why the written data requirements often tell only part of the story.

Beyond the Technical Dossier

Why social, political, institutional, and communication dynamics can be as important as the scientific data package in determining regulatory outcomes.

A 32-Country Perspective

Comparative insights across regulatory systems, ranging from Brazil’s increasingly streamlined pathways to the prolonged and complex approval processes encountered in Europe.

Practical Market Entry

What a regulatory professional should understand on Day One when evaluating a new country, including regulatory authority, product classification, data expectations, timelines, local representation, institutional capacity, and unwritten practices.

Free and Accessible Regulatory Knowledge

How Terry’s collaboration with the Agricultural & Food Systems Institute is making global regulatory intelligence freely available to support industry, regulators, researchers, and capacity-building initiatives.

The United States in Global Context

Where the U.S. EPA biopesticide system sits within the broader international regulatory landscape—and what the United States may learn from approaches being used in other markets.

Whilst Brazil revolutionised biocontrol approvals with 12-18 month timelines through federal harmonisation, the USA presents a stark contrast: 50 different state regulations, 50 different laws, and NO federal definition for biostimulants. This panel brings together regulatory experts from both regions to reveal what the USA can learn from LATAM's policy success—and the practical strategies biocontrol companies need to navigate America's fragmented regulatory maze.

Key Discussion Points:

• USA's Regulatory Reality: Multi-state market access strategies, hidden costs of regulatory inconsistency, and what the industry desperately needs from policymakers

• LATAM's Success Story: How Brazil's streamlined regulatory framework accelerated biocontrol adoption and what policy alignment with producers looks like in practice

• Comparative Intelligence: Actionable insights for companies operating across both markets—from EPA navigation to leveraging Brazil's 12-18 month advantage

• Future Vision: What regulatory harmonisation could mean for USA biocontrol innovation and competitiveness

• Address the manufacturing challenges of mass-producing living organisms at commercial scale

• Explore quality control, consistency, and cost-effectiveness in biocontrol production

• Discuss what data convinces farmers, retailers, and regulators that biocontrol products work

• Examine trial design, statistical approaches, and communicating results effectively

• Explore successful partnership models between academia, start-ups, and established ag companies

• Discuss licensing agreements, co-development strategies, and maintaining innovation while scaling

• Provide insights into what venture capital, strategic investors, and grant programmes look for in biocontrol ventures

• Discuss valuation, milestones, and building investor confidence in biological solutions

• Examine the psychological, economic, and practical barriers preventing wider biocontrol adoption

• Discuss strategies to build farmer confidence, demonstrate ROI, and simplify decision-making

• Envision California agriculture in 2035: integrated pest management, reduced chemical reliance, and thriving biocontrol markets

• Discuss policy support, education needs, and infrastructure development to accelerate the transition